ENTITY
Consun Pharmaceutical

Consun Pharmaceutical (1681 HK)

59
Analysis
Health Care • China
Consun Pharmaceutical Group is a modern pharmaceutical enterprise engaged in the research, development, production, and marketing of modern Chinese medicines and medical imaging contrast mediums. It also manufactures and sells traditional Chinese medicines. Key products include Uremic Clearance Granule for kidney disease, Gadopentetate Dimeglumine Injection as a medical contrast medium, and Iron Dextran Oral Solution. The company was founded in 1997 and is headquartered in Guangzhou, China.
more
•25 Jul 2025 10:40

Hong Kong Buybacks Weekly (Jul 25th): China Eastern Airlines, Yum China, Vitasoy International

We analyzed the Hong Kong buyback data in the past week and highlight the top 3 companies that repurchased the most shares were China Eastern...

Logo
525 Views
Share
bullish•IFBH
•25 Jul 2025 06:33

HSCI Index Rebalance Preview and Stock Connect (Sep 2025): Plenty of Recent IPOs Could Be Added

The forecast adds to the index and Stock Connect are up 9.7% on average this month while the forecast deletes from the index and Stock Connect are...

Logo
1.7k Views
Share
•18 Jul 2025 10:40

Hong Kong Buybacks Weekly (Jul 18th): AIA, Yum China, Cimc

We analyzed the Hong Kong buyback data in the past week and highlight the top 3 companies that repurchased the most shares were AIA (1299 HK), Yum...

Logo
595 Views
Share
•17 Jul 2025 19:20

Quiddity Leaderboard Hang Seng Biotech Sep25: 20 Deletions Likely Due to Major Methodology Change

A recent methodology change will result in a drop in constituent count from 50 to 30. This would trigger 20 deletions. These expected DELs could...

Share
•11 Jul 2025 09:51

Hong Kong Buybacks Weekly (Jul 11th): Tencent, AIA, Wuxi Biologics

We analyzed the Hong Kong buyback data in the past week and highlight the top 3 companies that repurchased the most shares were Tencent (700 HK),...

Logo
685 Views
Share
x